Methotrexate Alters the Expression of microRNA in Fibroblast-like Synovial Cells in Rheumatoid Arthritis.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
26 Oct 2021
Historique:
received: 06 10 2021
revised: 21 10 2021
accepted: 22 10 2021
entrez: 13 11 2021
pubmed: 14 11 2021
medline: 16 12 2021
Statut: epublish

Résumé

We aimed to investigate the effect of methotrexate (MTX) on microRNA modulation in rheumatoid arthritis fibroblast-like synovial cells (RA-FLS). RA-FLS were treated with MTX for 48 h. We then performed miRNA array analysis to investigate differentially expressed miRNAs. Transfection with miR-877-3p precursor and inhibitor were used to investigate the functional role of miR-877-3p in RA-FLS. Gene ontology analysis was used to investigate the cellular processes involving miR-877-3p. The production of cytokines/chemokines was screened by multiplex cytokine/chemokine bead assay and confirmed by ELISA and quantitative real-time PCR. The migratory and proliferative activities of RA-FLS were analyzed by wound healing assay and MKI-67 expression. MTX treatment altered the expression of 13 miRNAs (seven were upregulated and six were downregulated). Among them, quantitative real-time PCR confirmed that miR-877-3p was upregulated in response to MTX (1.79 ± 0.46-fold,

Identifiants

pubmed: 34768991
pii: ijms222111561
doi: 10.3390/ijms222111561
pmc: PMC8584010
pii:
doi:

Substances chimiques

MicroRNAs 0
Methotrexate YL5FZ2Y5U1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Society for the Promotion of Science
ID : Grants-in-Aid for Scientific Research 16K19605 to Dr. Iwamoto

Références

Oncotarget. 2016 Aug 9;7(32):51773-51783
pubmed: 27429046
Arch Pharm Res. 2014 Oct;37(10):1286-94
pubmed: 24988987
Cancer Biol Med. 2021 Jun 10;:
pubmed: 34110722
PLoS One. 2016 Mar 31;11(3):e0151246
pubmed: 27031951
Blood. 1980 Dec;56(6):947-58
pubmed: 7002232
EMBO Mol Med. 2012 Sep;4(9):896-909
pubmed: 22887866
Eur Rev Med Pharmacol Sci. 2018 Oct;22(20):6625-6632
pubmed: 30402834
Arthritis Rheum. 1988 Mar;31(3):315-24
pubmed: 3358796
Blood. 1989 Dec;74(8):2769-70
pubmed: 2510837
Ther Adv Musculoskelet Dis. 2018 Feb;10(2):29-38
pubmed: 29387176
Br J Pharmacol. 2003 Feb;138(3):501-11
pubmed: 12569075
Clin Exp Immunol. 2004 Aug;137(2):430-6
pubmed: 15270863
Pharmacol Res. 2021 Nov;173:105887
pubmed: 34536550
Rheumatology (Oxford). 2015 Jan;54(1):178-87
pubmed: 25118313
J Rheumatol. 2018 Jan;45(1):53-61
pubmed: 29142030
Front Pharmacol. 2021 Aug 26;12:716081
pubmed: 34512345
BMC Cancer. 2020 Sep 25;20(1):924
pubmed: 32977766
Curr Pharm Biotechnol. 2018;19(1):79-86
pubmed: 29667551
J Rheumatol. 2015 Jun;42(6):943-7
pubmed: 25934826
J Immunol. 2003 May 15;170(10):4986-95
pubmed: 12734342
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
J Rheumatol. 1987 Feb;14(1):9-11
pubmed: 3033240
Apoptosis. 2005 Aug;10(4):895-907
pubmed: 16133879
Ann Rheum Dis. 2001 Aug;60(8):729-35
pubmed: 11454634
Immunopharmacology. 2000 Apr;47(1):35-44
pubmed: 10708808
Cytokine. 2015 Dec;76(2):527-536
pubmed: 26321413
J Cell Physiol. 2017 Jul;232(7):1907-1913
pubmed: 27982429
J Cell Physiol. 2011 Jul;226(7):1868-78
pubmed: 21506117
Apoptosis. 2006 Mar;11(3):389-99
pubmed: 16520895
Z Rheumatol. 1992 May-Jun;51(3):121-6
pubmed: 1502858
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2746-51
pubmed: 16477010
Arthritis Res Ther. 2017 May 31;19(1):110
pubmed: 28569176
Arthritis Rheum. 1989 Sep;32(9):1065-73
pubmed: 2476134
Biochem Pharmacol. 2018 Sep;155:110-123
pubmed: 29944870
Ann Rheum Dis. 1996 Apr;55(4):237-42
pubmed: 8733440
Immunol Med. 2019 Dec;42(4):156-161
pubmed: 31770498
Cell. 2010 Oct 1;143(1):21-6
pubmed: 20887887
Clin Rheumatol. 2019 Mar;38(3):877-884
pubmed: 30511295
Curr Rheumatol Rep. 2020 May 13;22(6):17
pubmed: 32405712
Ann Rheum Dis. 2020 Jun;79(6):685-699
pubmed: 31969328
Front Immunol. 2021 Mar 03;12:633201
pubmed: 33746971
Ann Rheum Dis. 2010 Sep;69(9):1580-8
pubmed: 20699241
Glia. 2006 Jan 15;53(2):115-23
pubmed: 16206159
Exp Ther Med. 2019 Jul;18(1):312-319
pubmed: 31258667

Auteurs

Naoki Iwamoto (N)

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8102, Japan.

Kaori Furukawa (K)

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8102, Japan.

Yushiro Endo (Y)

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8102, Japan.

Toshimasa Shimizu (T)

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8102, Japan.

Remi Sumiyoshi (R)

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8102, Japan.

Masataka Umeda (M)

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8102, Japan.

Tomohiro Koga (T)

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8102, Japan.
Center for Bioinformatics and Molecular Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8102, Japan.

Shin-Ya Kawashiri (SY)

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8102, Japan.
Division of Advanced Preventive Medical Sciences, Department of Community Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8102, Japan.

Takashi Igawa (T)

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8102, Japan.

Kunihiro Ichinose (K)

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8102, Japan.

Mami Tamai (M)

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8102, Japan.

Tomoki Origuchi (T)

Department of Physical Therapy, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8102, Japan.

Atsushi Kawakami (A)

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8102, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH